Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2012
09/19/2012EP2500362A2 Humanized antibodies against TL1A
09/19/2012EP2500361A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
09/19/2012EP2500359A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500358A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500357A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500356A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500355A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500354A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500353A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500352A1 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500350A2 Composite of a protein comprising zinc oxide-bonding peptides and zinc oxide nanoparticles, and use thereof
09/19/2012EP2500037A2 Use of TNF alpha inhibitor for treatment of erosive polyarthritis
09/19/2012EP2500036A1 MET inhibitors for enhancing radiotherapy efficacy
09/19/2012EP2500035A1 Pharmaceutical formulation containing immunglobulin
09/19/2012EP2500034A1 Therapeutic agent for psoriasis or atopic dermatitis
09/19/2012EP2500033A1 Method for preparing muliple antigen glycopeptide carbohydrate conjugates
09/19/2012EP2500030A2 Use of complement pathway inhibitors to treat ocular diseases
09/19/2012EP2499244A1 Anti-trypanosomiasis vaccines and diagnostics
09/19/2012EP2499161A1 Antibodies specific for claudin 6 (cldn6)
09/19/2012EP2499158A1 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
09/19/2012EP2499157A1 Anti-trypanosome therapeutic and diagnostic applications
09/19/2012EP2498817A2 A method of promoting dendritic spine density
09/19/2012EP2498816A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses
09/19/2012EP2498815A1 Vaccine composition
09/19/2012EP2498814A2 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
09/19/2012EP2498813A1 Actinobacillus suis antigens
09/19/2012EP2498812A1 Immunizing composition for reducing streptococcal infections
09/19/2012EP2498811A1 Bacteremia-associated antigen from staphylococcus aureus
09/19/2012EP2498810A1 Treatment of sleep disordered breathing with neurotoxin
09/19/2012EP2498809A1 Immune system modulating composition
09/19/2012EP2498808A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
09/19/2012EP2498807A2 Compositions, methods and uses for stimulating immune responses
09/19/2012EP2498795A2 Granulysin in immunotherapy
09/19/2012CN1889979B IP-10 antibodies and their uses
09/19/2012CN1874787B Composition for the prophylaxis/treatment of HBV infections and HBV-mediated diseases
09/19/2012CN1681529B Immunogenic compositions and diagnostic and therapeutic uses thereof
09/19/2012CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
09/19/2012CN102686609A Modified variable domain molecules and methods for producing and using same
09/19/2012CN102686241A Antibody formulation
09/19/2012CN102686239A Stable anti-TNFR1 polypeptides, antibody variable domains & antagonists
09/19/2012CN102686238A Protein matrix vaccines of improved immunogenicity
09/19/2012CN102676570A Recombinant bacillus subtilis immunoglobulin binding protein functional-domain expression vector and application thereof
09/19/2012CN102676547A Fusion protein containing neutralizing epitope gene of C-terminal of encephalitis-B E protein and vaccine containing fusion protein
09/19/2012CN102676471A Chicken IL-18 (Interleukin-18) and Newcastle disease virus HN (Hemagglutinin-neuraminidase) gene recombinant fusion protein and application
09/19/2012CN102676461A Method for producing virus-like particles by utilizing drosophila cells and application
09/19/2012CN102676455A Preparation method for dendritic cell of umbilical cord blood source and dendritic cell vaccine
09/19/2012CN102676421A Bordetella bronchiseptica gene deletion strain, vaccine prepared from Bordetella bronchiseptica gene deletion strain and application
09/19/2012CN102676419A Salmonella typhi gene deletion strain, vaccine prepared from salmonella typhi gene deletion strain and application
09/19/2012CN102675471A Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
09/19/2012CN102675462A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/19/2012CN102675460A Anti-tumor necrosis factor alpha human-derived antibody
09/19/2012CN102675459A Preparation method of THP protein monoclonal antibody
09/19/2012CN102675446A 38kDa antigen for Baylisascaris schroederi of giant pandas, preparation method for antigen and application of antigen
09/19/2012CN102675445A Ubiquitin-like modified protein, preparation and application thereof
09/19/2012CN102675439A Preparation method and application of recombination ryegrass pollen allergen and mutant thereof
09/19/2012CN102675433A Recombinant protein of methicillin-resistant staphylococcus aureus IsdB protein active segment, preparation method thereof and application thereof
09/19/2012CN102675432A Immunogens from uropathogenic escherichia coli
09/19/2012CN102675430A Hepatitis B virus surface L protein related peptide
09/19/2012CN102675425A Functional mycobacterium tuberculosis antigen polypeptide and application thereof
09/19/2012CN102671209A Heat-resistant freeze-drying protective agent for newcastle disease live vaccines and preparation method
09/19/2012CN102671208A Heat-resisting freeze-dried protective agent for live vaccine for chicken infectious bursal diseases and preparation method for heat-resisting freeze-dried protective agent
09/19/2012CN102671207A Newcastle disease and avian infectious bronchitis bigeminal live vaccine heat-resisting freeze-drying protective agent and preparation method
09/19/2012CN102671196A Combinations of therapeutic agents for treating cancer
09/19/2012CN102671194A Human vaccine for preventing hydrophobia and tetanus
09/19/2012CN102671193A Herpes simplex virus II type gene recombined attenuated live vaccine and preparation method thereof
09/19/2012CN102671192A Human diploid cell rabies vaccine and preparation method thereof
09/19/2012CN101899421B Recombinant baculovirus and construction method and application thereof
09/19/2012CN101815505B Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
09/19/2012CN101568349B Methods of reducing phosphate absorption
09/19/2012CN101553248B Novel H5 proteins, nucleic acid encoding same and vectors, and their medicinal use
09/19/2012CN101472606B Methods for the treatment of flavivirus infection, molecules and uses thereof
09/19/2012CN101455838B Preparation method of avian infectious brunchitis virus HA antigen
09/19/2012CN101422620B Cryptosporidum parvum bivalent nucleic acid vaccine and preparation method thereof
09/19/2012CN101297968B Preparation of pig serum immunoglobulin microsphere novel dosage form
09/19/2012CN101166763B Stabilized anti-hepatitis B (HBV) antibody formulations
09/18/2012USRE43672 Anti-IL-6 antibodies, compositions, methods and uses
09/18/2012US8268981 Plasmodium malariae and plasmodium ovale genes and uses thereof
09/18/2012US8268976 Flea GABA receptor subunit nucleic acid molecules
09/18/2012US8268973 Anti-amyloid antibodies
09/18/2012US8268971 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
09/18/2012US8268888 Therapy of malignant neoplasias
09/18/2012US8268801 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis
09/18/2012US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
09/18/2012US8268615 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
09/18/2012US8268596 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
09/18/2012US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity
09/18/2012US8268566 Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis
09/18/2012US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
09/18/2012US8268346 Methods of treating hot flashes with formulations for transdermal or transmucosal application
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268330 Hypoxia inducible factor inducer and methods for using the same
09/18/2012US8268329 Modified Vaccinia ankara virus variant
09/18/2012US8268328 Immediate protection against pathogens via MVA
09/18/2012US8268327 Immediate protection against pathogens via MVA
09/18/2012US8268326 Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
09/18/2012US8268325 Modified Vaccinia Ankara virus variant
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012US8268323 Conformationally stabilized HIV envelope immunogens
09/18/2012US8268322 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
09/18/2012US8268321 Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and DDS using the same
1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 1823